Safety and efficacy of rituximab in steroid-refractory chronic GVHD

被引:11
作者
Clavert, A. [1 ]
Chevallier, P. [1 ]
Guillaume, T. [1 ]
Delaunay, J. [1 ]
Le Gouill, S. [1 ,2 ,3 ,4 ]
Mahe, B. [1 ]
Dubruille, V. [1 ]
Gastinne, T. [1 ]
Blin, N. [1 ]
Moreau, P. [1 ,2 ,3 ]
Mohty, M. [1 ,2 ,3 ,4 ]
机构
[1] Ctr Hosp & Univ CHU Nantes, Serv Hematol Clin, Nantes, France
[2] Univ Nantes, Nantes, France
[3] INSERM, CRNCA, UMR 892, Nantes, France
[4] CHU Nantes, CI2C, F-44035 Nantes 01, France
关键词
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; ONSET NEUTROPENIA;
D O I
10.1038/bmt.2012.203
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:734 / 736
页数:3
相关论文
共 10 条
[1]   Clinical impact and predisposing factors of delayed-onset neutropenia after autologous hematopoietic stem-cell transplantation for B-cell non-Hodgkin lymphoma: association with an incremental risk of infectious events [J].
Kato, H. ;
Yamamoto, K. ;
Matsuo, K. ;
Oki, Y. ;
Taji, H. ;
Kuwatsuka, Y. ;
Seto, M. ;
Kagami, Y. ;
Morishima, Y. .
ANNALS OF ONCOLOGY, 2010, 21 (08) :1699-1705
[2]   Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis [J].
Kharfan-Dabaja, Mohamed A. ;
Mhaskar, Asmita R. ;
Djulbegovic, Benjamin ;
Cutler, Corey ;
Mohty, Mohamad ;
Kumar, Ambuj .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) :1005-1013
[3]   B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy [J].
Kim, Seok Jin ;
Won, Jong Ho .
LEUKEMIA & LYMPHOMA, 2012, 53 (01) :19-25
[4]   Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism [J].
Li, Szu-Chin ;
Chen, Yi-Chun ;
Evens, Andrew M. ;
Lee, Ching-Chih ;
Liao, Hui-Fen ;
Yu, Chi-Chia ;
Tung, Ya-Ting ;
Su, Yu-Chieh .
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (10) :810-812
[5]   Rituximab Administration within 6 Months of T Cell-Depleted Allogeneic SCT is Associated with Prolonged Life-Threatening Cytopenias [J].
McIver, Zachariah ;
Stephens, Nicole ;
Grim, Andrew ;
Barrett, A. John .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (11) :1549-1556
[6]   Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission [J].
Miklos, DB ;
Kim, HT ;
Miller, KH ;
Guo, LX ;
Zorn, E ;
Lee, SJ ;
Hochberg, EP ;
Wu, CJ ;
Alyea, EP ;
Cutler, C ;
Ho, V ;
Soiffer, RJ ;
Antin, JH ;
Ritz, J .
BLOOD, 2005, 105 (07) :2973-2978
[7]   Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen [J].
Mohty, M ;
Jacot, W ;
Faucher, C ;
Bay, JO ;
Zandotti, C ;
Collet, L ;
Choufi, B ;
Bilger, K ;
Tournilhac, O ;
Vey, N ;
Stoppa, AM ;
Coso, D ;
Gastaut, JA ;
Viens, P ;
Maraninchi, D ;
Olive, D ;
Blaise, D .
LEUKEMIA, 2003, 17 (11) :2168-2177
[8]   Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation [J].
Peric, Z. ;
Cahu, X. ;
Chevallier, P. ;
Brissot, E. ;
Malard, F. ;
Guillaume, T. ;
Delaunay, J. ;
Ayari, S. ;
Dubruille, V. ;
Le Gouill, S. ;
Mahe, B. ;
Gastinne, T. ;
Blin, N. ;
Saulquin, B. ;
Harousseau, J-L ;
Moreau, P. ;
Milpied, N. ;
Coste-Burel, M. ;
Imbert-Marcille, B-M ;
Mohty, M. .
LEUKEMIA, 2011, 25 (06) :932-938
[9]   Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab [J].
von Bonin, Malte ;
Oelschlaegel, Uta ;
Radke, Joergen ;
Stewart, Michelle ;
Ehninger, Gerhard ;
Bornhauser, Martin ;
Platzbecker, Uwe .
TRANSPLANTATION, 2008, 86 (06) :875-879
[10]   Treatment of refractory chronic GVHD with rituximab: a GITMO study [J].
Zaja, F. ;
Bacigalupo, A. ;
Patriarca, F. ;
Stanzani, M. ;
Van Lint, M. T. ;
Fili, C. ;
Scime, R. ;
Milone, G. ;
Falda, M. ;
Vener, C. ;
Laszlo, D. ;
Alessandrino, P. E. ;
Narni, F. ;
Sica, S. ;
Olivieri, A. ;
Sperotto, A. ;
Bosi, A. ;
Bonifazi, F. ;
Fanin, R. .
BONE MARROW TRANSPLANTATION, 2007, 40 (03) :273-277